首頁 > 市場調查報告書 > 醫療設備

整形外科關節移植

市場調查報告書

商品編碼

1606538

全球骨科關節重建市場 - 2024-2031

Global Orthopedic Joint Reconstruction Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球骨科聯合重建市場規模達202億美元，預計2031年將達到365.6億美元，2024-2031年預測期間複合年成長率為7.7%。

骨科關節重建是一種外科手術，旨在恢復因損傷、疾病或退化而受損的關節的結構和功能。這個過程通常涉及去除受影響的關節並用人造關節（稱為假體）替換它，旨在模仿健康關節的自然運動和功能。

骨科關節重建包括修復或取代受損關節的各種手術技術，以減輕骨關節炎、類風濕性關節炎、創傷或先天畸形等疾病患者的疼痛、恢復活動能力並改善生活品質。這些因素推動了全球骨科聯合重建市場的擴張。

市場動態：

驅動程式和限制

骨科疾病的盛行率不斷增加

骨科疾病的盛行率日益增加，極大地推動了全球骨科關節重建市場的成長，預計將在整個市場預測期內推動成長。

包括骨關節炎、類風濕性關節炎和各種肌肉骨骼疾病在內的骨科疾病的盛行率不斷上升，是推動全球骨科關節重建市場成長的主要因素。隨著人口老化，這些疾病的發生率上升，導致對聯合重建手術的需求更大。

根據2023 年11 月《柳葉刀風濕病學》研究出版物，2020 年全球約有4.94 億人受到其他肌肉骨骼疾病的影響。數將從 2020 年到 2050 年，病例數將增加 115%，預計到 2050 年，流行病例數將達到 10.6 億。

研究發現，這些疾病的全球年齡標準化盛行率在女性中比男性高 47.4%，且盛行率隨著年齡的成長而增加，男女在 65 至 69 歲之間達到高峰。肌肉骨骼疾病是全球殘障壽命 (YLD) 的第六大原因，約佔 4,270 萬個殘障壽命，並導致約 83,100 人死亡。所有這些因素都對全球骨科關節重建市場提出了需求。

此外，骨科疾病數量的增加需要骨科產業的創新解決方案。對於這個產業的關鍵參與者來說，關鍵措施和先進產品的推出將推動骨科關節重建市場的成長。例如，2024 年 11 月，強生醫療科技在 2024 年美國髖關節和膝關節外科醫生協會 (AAHKS) 年會上推出了新的關節重建解決方案，強調了「行動解決方案」計劃。該計劃旨在整合先進的手術技術、創新的植入物和數據驅動的支援技術，以增強關節重建手術。

該計劃代表了一項綜合策略，結合了骨科護理的各個要素，重點是提高手術精確度和患者治療效果。透過將先進的手術方法與創新的植入物設計相結合並利用資料分析，強生醫療科技致力於將關節手術轉變為更有效率、更有效的手術。

此外，2023年10月，強生醫療科技子公司DePuy Synthes在歐洲市場正式推出VELYS機器人輔助解決方案，標誌著骨科手術技術的重大進步。此創新系統專為全膝關節置換術 (TKA) 設計，旨在提高手術精確度和病患治療效果。所有這些因素都對全球骨科關節重建市場提出了需求。

此外，對微創手術的需求不斷成長有助於全球骨科關節重建市場的擴張。

植入物成本高

植入物的高成本將阻礙全球骨科關節重建市場的成長。這些高昂的費用可能會阻礙患者接受必要的手術，尤其是在醫療保健預算有限的發展中國家。昂貴的植入物造成的財務壓力可能會導致治療延誤，對患者的治療結果產生負面影響，並阻礙骨科關節重建市場的整體成長。

根據2024 年7 月《骨科商業雜誌》文章新聞報道，PubMed 上的一項研究產生了469 篇與「膝關節置換術植入總成本」相關的文章，其中14 篇提供了對標準膝關節植入物成本以及與主要膝關節置換術相關的總費用的新估計。標準膝關節植入物的平均成本為 5,336 美元 ± 1,671 美元，而初次 TKA 的平均總成本為 23,907 美元 ± 9,514 美元。值得注意的是，標準膝關節植入物的成本佔初次 TKA 總費用的 22.3%。因此，上述因素可能限制全球骨科聯合重建市場的潛在成長。

Orthopedic joint reconstruction is a surgical procedure that aims to restore the structure and functionality of a joint damaged by injury, disease, or degeneration. The process typically involves removing the affected joint and replacing it with an artificial joint, known as a prosthesis, designed to mimic the natural movement and function of a healthy joint.

Orthopedic joint reconstruction includes various surgical techniques that repair or replace damaged joints to alleviate pain, restore mobility, and improve the quality of life for patients suffering from conditions such as osteoarthritis, rheumatoid arthritis, trauma, or congenital deformities. These factors have driven the global orthopedic joint reconstruction market expansion.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Orthopedic Disorders

The increasing prevalence of orthopedic disorders is significantly driving the growth of the global orthopedic joint reconstruction market and is expected to drive throughout the market forecast period.

The increasing prevalence of orthopedic conditions, including osteoarthritis, rheumatoid arthritis, and various musculoskeletal disorders, is a major factor driving global orthopedic joint reconstruction growth in the market. As the population ages, the incidence of these conditions rises, resulting in greater demand for joint reconstruction surgeries.

According to The Lancet Rheumatology research publication in November 2023, globally, there were approximately 494 million individuals affected by other musculoskeletal disorders in 2020. This represents a substantial increase of 123.4% from 221 million cases in 1990. Projections indicate that the number of cases will rise by 115% from 2020 to 2050, reaching an estimated 1,060 million prevalent cases by 2050. Most regions are expected to see at least a 50% increase in cases during this period.

The global age-standardized prevalence of these disorders was found to be 47.4% higher in females than in males, and the prevalence increased with age, peaking at ages 65 to 69 for both sexes. Musculoskeletal disorders ranked as the sixth leading cause of years lived with disability (YLDs) worldwide, accounting for approximately 42.7 million YLDs and were associated with about 83,100 deaths. All these factors demand the global orthopedic joint reconstruction market.

Furthermore, the increased number of orthopedic disorders needs innovative solutions in the orthopedic industry. For this key player in the industry, key initiatives and advanced product launches would propel this orthopedic joint reconstruction market growth. For instance, in November 2024, Johnson & Johnson MedTech introduced its new joint reconstruction solutions at the 2024 American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting, highlighting the Solutions in Motion initiative. This initiative aims to integrate advanced surgical techniques, innovative implants, and data-driven enabling technologies to enhance joint reconstruction procedures.

The initiative represents a comprehensive strategy that combines various elements of orthopedic care, focusing on improving surgical precision and patient outcomes. By integrating advanced surgical methods with innovative implant designs and leveraging data analytics, Johnson & Johnson MedTech seeks to transform joint surgeries into more efficient and effective procedures.

Also, in October 2023, DePuy Synthes, a subsidiary of Johnson & Johnson MedTech, officially launched the VELYS Robotic-Assisted Solution in the European market, marking a significant advancement in orthopedic surgery technology. This innovative system is designed specifically for total knee arthroplasty (TKA) and aims to enhance surgical precision and patient outcomes. All these factors demand the global orthopedic joint reconstruction market.

Moreover, the rising demand for minimally invasive procedures contributes to the global orthopedic joint reconstruction market expansion.

High Costs of Implants

The high costs of implants will hinder the growth of the global orthopedic joint reconstruction market. These high expenses can discourage patients from undergoing essential surgeries, especially in developing nations where healthcare budgets are constrained. The financial strain caused by expensive implants may result in delays in treatment, negatively impacting patient outcomes and hindering overall orthopedic joint reconstruction market growth.

According to the Journal of Orthopaedic Business article news in July 2024, a study on PubMed yielded 469 articles related to "total knee arthroplasty implant cost," of which 14 provided new estimates for the cost of standard knee implants and the total expenses associated with primary total knee arthroplasty (TKA). The average cost of a standard knee implant was found to be $5,336 +- $1,671, while the mean total cost for primary TKA was $23,907 +- $9,514. Notably, the cost of the standard knee implant accounts for 22.3% of the overall expense for a primary TKA. Thus, the above factors could be limiting the global orthopedic joint reconstruction market's potential growth.

Segment Analysis

The global orthopedic joint reconstruction market is segmented based on product type, technique, procedure, end-user, and region.

Product Type:

The knee implants segment is expected to dominate the global orthopedic joint reconstruction market share

The knee implants segment holds a major portion of the global orthopedic joint reconstruction market share and is expected to continue to hold a significant portion of the global orthopedic joint reconstruction market share during the forecast period.

The knee implant segment within the global orthopedic joint reconstruction market is essential for meeting the growing demand for knee replacement surgeries. This segment includes various types of implants designed to replace damaged or diseased knee joints, primarily due to conditions like osteoarthritis, rheumatoid arthritis, and traumatic injuries.

According to the World Health Organization (WHO) data in July 2023, Osteoarthritis (OA) is a degenerative joint disease that affects the entire joint, including the surrounding tissues. It is most commonly found in the knees, hips, spine, and hands. With a global prevalence of 365 million, the knee is the most frequently affected joint, followed by the hip and hand. Among those with osteoarthritis, approximately 344 million individuals experience moderate to severe symptoms that could benefit from rehabilitation. The incidence of knee osteoarthritis is particularly high among older adults, with over 22% of individuals aged 40 and above globally affected by this condition. As the population ages, the demand for knee replacement surgeries is expected to rise significantly.

There is a growing trend toward minimally invasive surgical procedures that reduce recovery times and enhance patient outcomes. These techniques are becoming increasingly popular among both surgeons and patients, driving demand for knee implants that support such approaches. Innovations in implant materials and designs, including the use of 3D printing technology and patient-specific implants, are improving the effectiveness and longevity of knee replacements. These advancements are attracting more patients to consider surgical interventions. Thus, all these factors demand the orthopedic joint reconstruction market.

Furthermore, key players in the industry product launches and approvals would drive this segment's growth in the orthopedic joint reconstruction market. For instance, in February 2024, the Asian Orthopaedic Institute (AOI) at SIMS Hospital in Chennai launched a new ceramic knee replacement system, marking a significant advancement in joint replacement surgery. This introduction is part of the hospital's commitment to providing innovative orthopedic solutions and improving patient care. Ceramic knee implants offer several significant advantages over traditional metal implants, making them an increasingly popular choice for patients undergoing knee replacement surgery.

Also, in November 2024, Zimmer Biomet Holdings, Inc. received a Food and Drug Administration (FDA) Premarket Approval Application (PMA) Supplement for its Oxford Cementless Partial Knee implant, marking a significant advancement in knee replacement technology. This approval is based on comprehensive safety and effectiveness data gathered from an Investigational Device Exemption (IDE) study and non-clinical testing specifically for cementless partial knee replacement (PKR). These factors have solidified the segment's position in the global orthopedic joint reconstruction market.

Geographical Analysis

North America is expected to hold a significant position in the global orthopedic joint reconstruction market share

North America holds a substantial position in the global orthopedic joint reconstruction market and is expected to hold most of the market share.

The incidence of orthopedic disorders, especially arthritis, is on the rise in North America. According to the Centers for Disease Control and Prevention (CDC), around 21.2% of U.S. adults (approximately 53.2 million people) were diagnosed with arthritis between 2019 and 2021. This significant prevalence is a major factor propelling the demand for joint reconstruction surgeries, as more individuals seek effective solutions to manage pain and regain mobility.

According to the American College of Rheumatology data in 2024, the U.S. performs a substantial number of joint replacement surgeries annually, with approximately 790,000 total knee replacements and 544,000 hip replacements conducted each year. This high volume reflects the ongoing need for effective orthopedic solutions and drives market growth.

The aging demographic in North America significantly contributes to market growth. As people age, they are more susceptible to joint-related issues, leading to an increased need for surgical interventions like total knee and hip replacements. As per Population Reference Bureau (PRB) data in January 2024, the number of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, the proportion of this age group within the total population is projected to rise from 17% to 23%.

Similarly, according to National Center for Biotechnology Information (NCBI) research data, by 2040, the number of U.S. adults with doctor-diagnosed arthritis is projected to increase by 49% to 78.4 million, representing 25.9% of all adults. Additionally, the number of adults experiencing arthritis-attributable activity limitation (AAAL) is expected to rise by 52% to 34.6 million, accounting for 11.4% of all adults.

Continuous advancements in medical technology have improved the effectiveness and safety of joint reconstruction surgeries. Innovations such as minimally invasive surgical techniques, robotic-assisted surgeries, and enhanced implant materials have made these procedures less invasive and more efficient, encouraging more patients to consider surgical options.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, investments, partnerships & collaborations, and product launches & approvals would propel the market growth.

For instance, in November 2024, Johnson & Johnson MedTech announced a strategic partnership with Responsive Arthroscopy, focusing on expanding its offerings in the sports soft tissue repair market. This collaboration involves an exclusive commercial distribution agreement in the United States, aimed at enhancing the range of advanced soft tissue repair solutions available for shoulder, foot, and ankle procedures.

Also, in October 2024, Smith+Nephew launched its Legion-hinged knee (HK) system featuring Oxinium implant technology in the U.S. market, representing a significant advancement in knee replacement solutions. This innovative system combines the benefits of metal durability, ceramic wear resistance, and superior corrosion resistance, aiming to improve patient outcomes and surgical efficiency. Thus, the above factors are consolidating the region's position as a dominant force in the global orthopedic joint reconstruction market.

Asia Pacific is growing at the fastest pace in the global orthopedic joint reconstruction market

Asia Pacific holds the fastest pace in the global orthopedic joint reconstruction market and is expected to hold most of the market share.

The prevalence of osteoporosis and arthritis is increasing across the Asia-Pacific region. According to the Asian Federation of Osteoporosis Societies (AFOS), hip fractures are projected to rise from 1.2 million in 2019 to 2.6 million by 2050. This growing incidence necessitates effective orthopedic interventions, including joint replacements.

Continuous innovations in orthopedic devices, such as minimally invasive surgical techniques and improved implant materials, are enhancing surgical outcomes and patient recovery times. Technologies like 3D printing, robotic-assisted surgery, and augmented reality are making surgical options more attractive to both patients and healthcare providers.

Many countries in the Asia-Pacific region are investing heavily in healthcare infrastructure, enhancing access to advanced medical treatments. This includes establishing specialized orthopedic centers equipped with the latest technology for joint reconstruction procedures. The increasing number of orthopedic surgeries performed annually in the Asia-Pacific region significantly contributes to market growth. As more patients seek surgical solutions for joint issues, the demand for advanced reconstruction devices continues to rise.

In Asia, particularly in countries like China and Japan, is rapidly increasing. This demographic shift is critical as older adults are more susceptible to joint-related disorders, leading to a higher demand for joint reconstruction surgeries.

Furthermore, key players in the region, product launches, and approvals would propel this global orthopedic joint reconstruction market growth. For instance, in April 2023, Prashanth Hospitals in New Delhi, launched a 4th Generation Robot specifically designed for joint reconstruction surgeries, marking a significant advancement in orthopedic technology. This innovative robot utilizes infrared cameras and optical trackers to create a precise 3D map of a patient's joint anatomy. This mapping capability allows for tailored implant selection and placement during surgical procedures, enhancing the overall accuracy of joint reconstruction.

Also, in January 2023, Aster Medcity launched a joint replacement robot following the successful completion of 2,500 joint replacement surgeries. This milestone reflects the hospital's commitment to advanced orthopedic care and the integration of robotic technology in surgical procedures in India.

The newly introduced robot is fully automated and designed for knee replacement surgeries. It enhances surgical precision by utilizing advanced imaging techniques, such as CT scans or MRIs, to create detailed 3D models of the patient's joint. This allows for personalized surgical planning tailored to each patient's unique anatomy. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global orthopedic joint reconstruction market.

Competitive Landscape

The major global players in the orthopedic joint reconstruction market include Johnson & Johnson (DePuy Synthes), Stryker, Smith + Nephew, Zimmer Biomet., Arthrex, Inc., Globus Medical, Enovis Corporation, Exactech, Inc., B. Braun SE, and MicroPort Scientific Corporation among others.

Key Developments

In October 2024, Aradhana Orthopedic Hospital launched Shivamogga's first fully automated robotic joint replacement system, marking a significant advancement in orthopedic surgery within the region. This state-of-the-art technology aims to enhance the precision and effectiveness of joint replacement procedures, improving patient outcomes and recovery times.
In July 2024, Orthofix Medical Inc. announced the 510(k) clearance and the first U.S. implantation of the Fitbone Transport and Lengthening System, a significant advancement in orthopedic technology designed to treat large bone defects in the femur and tibia. This innovative device is particularly useful for patients suffering from trauma, infections, or malignant conditions that result in substantial bone loss.
In June 2024, Meril launched the MISSO ortho-robot, a fully indigenous surgical robot designed specifically for knee replacement surgeries. This innovative technology promises to significantly reduce the costs associated with these procedures, making them more accessible to a broader range of patients in India.

Why Purchase the Report?

Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
Market Positioning: Analysis of product performance and growth potential for optimized strategies.
Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
Market Expansion: Strategies for entering new markets and forming partnerships.
Regional Opportunities: Identification of high-growth regions and investment prospects.
Supply Chain Optimization: Assessment of risks and distribution strategies.
Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
Post-Market Surveillance: Enhanced safety and access through post-market data.
Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global orthopedic joint reconstruction market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technique
3.3. Snippet by Procedure
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Orthopedic Disorders
- 4.1.2. Restraints
  - 4.1.2.1. High Costs of Implants
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Knee Implants *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Hip Implants
6.4. Shoulder Implants
6.5. Ankle Implants
6.6. Others

7. By Technique

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 7.1.2. Market Attractiveness Index, By Technique
7.2. Joint Replacement*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Osteotomy
7.4. Arthroscopy
7.5. Resurfacing
7.6. Arthrodesis
7.7. Others

8. By Procedure

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 8.1.2. Market Attractiveness Index, By Procedure
8.2. Total Replacement*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Partial Replacement
8.4. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Orthopedic Clinics
9.4. Ambulatory Surgical Centers (ASCs)
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Johnson & Johnson (DePuy Synthes) *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Stryker
12.3. Smith + Nephew
12.4. Zimmer Biomet.
12.5. Arthrex, Inc.
12.6. Globus Medical
12.7. Enovis Corporation
12.8. Exactech, Inc.
12.9. B. Braun SE
12.10. MicroPort Scientific Corporation

LIST NOT EXHAUSTIVE